Fortune 100 companies trust Matthew Kent to prosecute and defend global price-fixing cartels and other complex disputes. The counsel he provides allows his clients to minimize risk while achieving their business objectives.
Matthew focuses on bet-the-company antitrust litigation and counseling, with experience in the competition issues at the forefront of the pharmaceutical industry. He has litigated cases in federal courts throughout the country.